(Q42242252)

English

Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis

scientific article published on 21 January 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Toshiaki Kogure

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Naoyuki Harada

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Takeshi Tatsumi

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hiroshi Fujinaga

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

323-328

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Vaccination in patients with chronic rheumatic or autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Mortality in established rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Trends in serious infections in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

The risk of tuberculosis in patients treated with TNF antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Tumor necrosis factor blockade and the risk of viral infection

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors

2 references

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

Vaccination under TNF blockade - less effective, but worthwhile

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2483-0

21 January 2018

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lower respiratory tract infections in patients with rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemagglutination-inhibiting antibody to influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24445384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-013-2483-0

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42242252&oldid=2249078710"